Not finding it? Sign in to also search OpenAlex live.
-
Treatment Free Remission after Nilotinib Plus Peg-Interferon Alpha Induction and Peg-Interferon Alpha Maintenance Therapy for Newly Diagnosed Chronic Myeloid Leukemia Patients; The Tiger Trial
Andreas Hochhaus, Andreas Burchert, Susanne Saußele, Gabriela Maria Baerlocher, Jiřı́ Mayer, Tim H. Brümmendorf, +21 more
21citations -
Fedratinib in combination with CC-486, an oral hypomethylating agent, in patients with accelerated phase myelofibrosis: Results from the phase I/II famy trial2025 Blood conference-abstract Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access
Nadja Jaekel, Susann Schulze, Christina Zahn, Andreas Wienke, Michael Richter, Steffen Koschmieder, +5 more
1citations -
OC12.4 - LBA_ECE_1141 - The safety and efficacy of eneboparatide, a parathyroid hormone 1 receptor agonist, in adults with chronic hypoparathyroidism: a phase 3, randomized, placebo-controlled study (CALYPSO)2026 European Journal of Endocrinology conference-abstract Medicine Parathyroid Disorders and Treatments Open access
Maria Luisa Brandi, Jeremy Turner, Steven Wai Ing, Istvan Takacs, Aliya Khan, Lynn Kohlmeier, +11 more
1citations -
I033 Reprogrammed human lateral ganglionic eminence precursors generate striatal neurons and restore motor function in a rat model of Huntington’s disease2024 conference-abstract Biochemistry, Genetics and Molecular Biology Pluripotent Stem Cells Research Open access
Lieke Burgers, Amy McCaughey‐Chapman, David Gordon, Laura Marriott, Willeke van Roon‐Mom, Bronwen J. Connor
0citations
11 results